Corporate Profile

LianBio (NASDAQ: LIAN) is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in Greater China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio’s model leverages a number of key elements, including transformative in-licensing, development and commercialization approaches designed to deliver innovative therapeutic solutions to patients. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets.

Stock Quote

Price

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Print Page
Email Alerts
RSS Feeds
Contact IR